Clinical Trial Update: Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating arsenic trioxide for metastatic liver cancer that cannot be removed by surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cancer

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: University of Pittsburgh | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED